OSCR

#920
Oscar Health, Inc. Class A Common Stock
31.8 1 USD
-0.01%
Market Price
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
31.72
32.21
년간 변동
10.69
33.55
일일 변동
-1.27%
월간 변동
+4.09%
6달 변화
+114.79%
년간 변동율
+69.29%
이전 종가
32.2 2
Open
32.0 9
저가
31.7 2
고가
32.2 1
양
419
전체 차트 열기

Financials

개요 성명 통계 Documents

2026

Current report, Q3 FY2026
Oscar Health, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Oscar Health, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Oscar Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Oscar Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Oscar Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Oscar Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Oscar Health, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Oscar Health, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Oscar Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Oscar Health, Inc. current report, Q1 FY2026
8-K

Oscar Health, Inc. current report, Q2 FY2025

Full document

Oscar Health, Inc. 8-K Summary

Business Context and Reporting Period

This Form 8-K reports the results of the 2025 Annual Meeting of Stockholders held on June 4, 2025. The filing covers the voting outcomes for director elections, auditor ratification, and executive compensation advisory votes.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.

Material Changes and Voting Results

As of the record date (April 10, 2025), there were 929,277,354 total votes available. A quorum was established with 825,961,296 votes represented. All three proposals were approved:

  • Item 1 (Director Election): All nine nominees were elected. Votes ranged from approximately 782 million to 804 million "FOR" votes per nominee. Broker non-votes totaled 21,272,090 for each nominee.
  • Item 2 (Auditor Ratification): PricewaterhouseCoopers LLP was ratified with 825,271,165 votes FOR, 581,597 AGAINST, and 108,534 ABSTAINED.
  • Item 3 (Executive Compensation): The advisory vote on executive compensation passed with 801,338,734 votes FOR, 3,246,195 AGAINST, and 104,277 ABSTAINED.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.

Key Facts for Investor Verification

  • Verify the dual-class voting structure: Class B shares carry 20 votes per share, significantly influencing the total vote count.
  • Confirm the high level of shareholder support for the board, with "FOR" votes exceeding 97% for all director nominees.
  • Note the significant number of broker non-votes (21,272,090) on the director election and executive compensation proposals, which did not affect the outcome but indicate shares held by brokers without voting instructions on those specific matters.
  • Review the Definitive Proxy Statement filed on April 25, 2025, for detailed biographies of the elected directors and the specific compensation metrics approved.

뉴스